Filing Details
- Accession Number:
- 0001140361-13-015214
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-02 16:46:35
- Reporting Period:
- 2013-04-01
- Filing Date:
- 2013-04-02
- Accepted Time:
- 2013-04-02 16:46:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402051 | William Lewis | C/O Insmed Inc. 9 Deer Park Drive, Suite C Monmouth Junction NJ 08852 | President And Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-04-01 | 9,816 | $7.58 | 34,154 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option-Right to Buy | $3.40 | 2013-09-10 | 2022-09-10 | 708,314 | 708,314 | Direct |
Common Stock | Stock Option-Right to Buy | $4.55 | 2013-09-28 | 2022-09-28 | 186,170 | 186,170 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2022-09-10 | 708,314 | 708,314 | Direct |
2022-09-28 | 186,170 | 186,170 | Direct |
Footnotes
- Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.46 to $7.73, inclusive. The reporting person undertakes to provide to Insmed Incorporated, any security holder of Insmed Incorporated or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- These options shall become exercisable with respect to 25% of the shares of common stock subject to this grant on September 10, 2013, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of September 10, 2013 thereafter through September 10, 2016.
- These options shall become exercisable with respect to 25% of the shares of common stock subject to this grant on September 28, 2013, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of September 28, 2013 thereafter through September 28, 2016.